Sell Your Medical Device Distribution

Medical device distribution businesses are valued differently than clinical practices — buyers focus on manufacturer relationships, contract exclusivity, and customer concentration rather than patient volume, though the business still typically falls within Healthcare's 6–9x EBITDA range.

What Buyers Look At

Buyers evaluating a distribution business typically dig into:

  • Manufacturer contract terms, exclusivity, and remaining term length
  • Customer concentration — how much revenue comes from your largest accounts
  • Sales representative retention and relationships
  • Territory rights and any geographic restrictions

Typical Valuation Range

6–9x EBITDA

Medical Device Distribution businesses are valued within the broader Healthcare Businesses range. Your specific financials, provider/staff dependency, and payer mix determine where you land.

Who's Buying

Strategic distributors looking to consolidate territories, and manufacturers considering bringing distribution in-house, are the most common buyers in this category. Nationally, private equity has named healthcare among the sectors it's most actively pursuing, with PE participation running in the 44-58% range across the industries it favors most, and strategic buyers often paying 10% or more above a PE offer when an acquisition fills a specific gap in their footprint. Overall healthcare deal volume cooled somewhat in the most recent reporting period, but deals for practice-level businesses like this one actually rose by roughly half over the same stretch — a sign buyers are still actively acquiring at this level even as larger platform deals slow.

Frequently Asked Questions

Does losing a manufacturer contract kill the deal?

It can significantly affect value if that contract represents a large share of revenue — contract diversification is one of the first things worth addressing before going to market.

How much does customer concentration matter?

A lot — if a handful of customers represent most of your revenue, buyers will price in that risk. Diversifying your customer base ahead of a sale can meaningfully improve your outcome.

Will my sales reps stay on after a sale?

Most buyers want to retain sales relationships, since reps often carry the customer trust that makes the territory valuable — retention terms are a standard part of deal discussions.

Is now a good time to sell a medical device distribution business?

Strategic buyers in healthcare have generally been willing to pay above what PE competitors offer — often 10% or more — when an acquisition fills a specific territory or product gap, which can work in your favor if you have a clean, well-documented territory. Your own contract terms and customer concentration still shape the actual outcome.

Other Healthcare Businesses We Value

Not quite the right fit? Here are the other business types Forefront works with in this category.